03 Feb 2025
// FDA
21 Aug 2024
// FDA
05 Aug 2024
// FDA
Latest Content by PharmaCompass
About
Industry Trade Show
Attending
09-11 April, 2025
CPhI North America CPhI North America
Industry Trade Show
Attending
20-22 May, 2025
Industry Trade Show
Booth #E1H39
24-26 June, 2025
CONTACT DETAILS
Events
Webinars & Exhibitions
Industry Trade Show
Attending
09-11 April, 2025
CPhI North America CPhI North America
Industry Trade Show
Attending
20-22 May, 2025
Industry Trade Show
Booth #E1H39
24-26 June, 2025
03 Feb 2025
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214844
21 Aug 2024
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218205
05 Aug 2024
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218169
15 May 2023
// HEALTH ET
https://health.economictimes.indiatimes.com/news/pharma/drug-approvals-launches/biophore-its-subsidiary-zenara-pharma-receive-first-approval-for-cannabidiol-in-india/100251790
02 May 2023
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212420
04 Apr 2023
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216842
Regulatory Info :
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : BREXPIPRAZOLE
Dosage Strength : 0.25MG
Packaging :
Approval Date :
Application Number : 213477
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : BREXPIPRAZOLE
Dosage Strength : 1MG
Packaging :
Approval Date :
Application Number : 213477
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : BREXPIPRAZOLE
Dosage Strength : 3MG
Packaging :
Approval Date :
Application Number : 213477
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : BREXPIPRAZOLE
Dosage Strength : 0.5MG
Packaging :
Approval Date :
Application Number : 213477
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : BREXPIPRAZOLE
Dosage Strength : 2MG
Packaging :
Approval Date :
Application Number : 213477
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : BREXPIPRAZOLE
Dosage Strength : 4MG
Packaging :
Approval Date :
Application Number : 213477
Regulatory Info :
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : NITAZOXANIDE
Dosage Strength : 500MG
Packaging :
Approval Date : 2025-02-03
Application Number : 214844
Regulatory Info : RX
Registration Country : USA
Inspections and registrations
ABOUT THIS PAGE